Predictive Factors for Acute and Late Urinary Toxicity After Permanent Prostate Brachytherapy: Long-Term Outcome in 712 Consecutive PatientsMira Keyes, William Morris, Stacy Miller et al.|International Journal of Radiation Oncology*Biology*Physics|2008Cited by 180
Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancerWilliam Morris, Scott Tyldesley, Mira Keyes et al.|Cancer|2012Cited by 112
Population-based Study of Biochemical and Survival Outcomes After Permanent 125I Brachytherapy for Low- and Intermediate-risk Prostate CancerWilliam Morris, Howard Pai, Mira Keyes et al.|Urology|2009Cited by 90
Rectal toxicity and rectal dosimetry in low-dose-rate 125I permanent prostate implants: A long-term study in 1006 patientsMira Keyes, William Morris, Ingrid Spadinger et al.|Brachytherapy|2011Cited by 69
Evaluation of Dosimetric Parameters and Disease Response After 125Iodine Transperineal Brachytherapy for Low- and Intermediate-Risk Prostate CancerWilliam Morris, Ryan Woods, Mira Keyes et al.|International Journal of Radiation Oncology*Biology*Physics|2008Cited by 64